Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
This could be the answer...
An arthritis drug that could delay the progression of type 1 diabetes has been hailed as “life changing”. A study by University College London (UCL) has raised hopes after the rheumatoid arthritis drug abatacept appeared to preserve the pancreas’ ability to produce insulin.
Off the back of their results, the UCL scientists hope the drug will delay the progression of type 1 diabetes by even longer than the two years it was investigated for. Trials must be carried out to confirm this, they added.
The team also believe patients at any stage of the disease could benefit, but only those who were newly diagnosed were enrolled on to the trial.
uk.finance.yahoo.com
An arthritis drug that could delay the progression of type 1 diabetes has been hailed as “life changing”. A study by University College London (UCL) has raised hopes after the rheumatoid arthritis drug abatacept appeared to preserve the pancreas’ ability to produce insulin.
Off the back of their results, the UCL scientists hope the drug will delay the progression of type 1 diabetes by even longer than the two years it was investigated for. Trials must be carried out to confirm this, they added.
The team also believe patients at any stage of the disease could benefit, but only those who were newly diagnosed were enrolled on to the trial.
'Life-changing' arthritis drug could halt type 1 diabetes in a third of patients
Nearly 4 million people in the UK had been diagnosed with diabetes in 2019, of whom 8% had type 1.